Rho/ROCK Pathway Regulates Migration and Invasion of Esophageal Squamous Cell Carcinoma by Regulating Caveolin-1

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2017 Dec 31

PMID 29288243

Citations 4

Authors

Zhaohui Liu

Jing Yu

Ruinuan Wu

Shengxin Tang

Xiaoman Cai

Guanghua Guo

Suzuan Chen

Affiliations

Soon will be listed here.

Abstract

BACKGROUND Esophageal squamous cell carcinoma (ESCC) is a common cancer with poor prognosis. Caveolin-1 (Cav1) and Rho/ROCK pathway play important roles in tumor metastasis, separately. However, less research was focused on the relationship between Cav1 and Rho/ROCK in ECSS metastasis. Therefore, we investigated the relationship between Cav1 and Rho/ROCK pathway in ESCC metastasis. MATERIAL AND METHODS Cav1 and phosphorylated Cav1 (PY14Cav1) were examined in ESCC and in adjacent and non-tumorous tissues from ESCC patients by immunohistochemistry (IHC). Small interfering RNA (siRNA) targeting Cav1 or Rho/ROCK inhibitor was used to treat EC109, Eca109, TE1, and TE13 cells. Western blotting (WB) was used to detect Cav1 and PY14Cav1 expression. The wound healing scratch test and transwell assays were used to assess migration and invasion. RESULTS Cav1 and PY14Cav1 were gradually expressed at higher levels in ECSS than in adjacent and non-tumor tissues as ESCC stage and lymphatic metastasis increased, and this difference was significant (P<0.05). Cav1 was expressed at higher levels in TE1 and TE13 than in EC109 and Eca109, while PY14Cav1 was enhanced in TE1 and TE13 cells but not in EC109 and Eca109, and the difference was significant (P<0.05). TE1 and TE13 had significantly (P<0.05) stronger motility, migratory, and invasion abilities than EC109 and Eca109 cells. Silencing Cav1 decreased PY14Cav1 expression in TE1 and TE13 cells, as well as suppressing the migration and invasion of all ECSS cells, and these differences were significant (P<0.05). Suppressing the Rho/ROCK pathway obviously inhibited Cav1 and PY14Cav1 expressions, as well as significantly (P<0.05) decreasing migration and invasion of ESCC cells. CONCLUSIONS Cav1 and PY14Cav1 were positively correlated with ESCC lymphatic metastasis and cancer stages. Rho/ROCK pathway activation promoted ESCC metastasis by regulating Cav1.

Citing Articles

Prognostic nutritional index and serum lactate dehydrogenase predict the prognosis of nasopharyngeal carcinoma patients who received intensity-modulated radiation therapy.

Zhang C, Zhan Z, Fang Y, Ruan Y, Lin M, Dai Z J Cancer Res Clin Oncol. 2023; 149(20):17795-17805.

PMID: 37934254 DOI: 10.1007/s00432-023-05485-5.

CCT6A promotes esophageal squamous cell carcinoma cell proliferation, invasion and epithelial-mesenchymal transition by activating TGF-β/Smad/c-Myc pathway.

Xia X, Zhao S, Chen W, Xu C, Zhao D Ir J Med Sci. 2023; 192(6):2653-2660.

PMID: 37017854 DOI: 10.1007/s11845-023-03357-y.

Caveolin-1 Expression at Metastatic Lymph Nodes Predicts Unfavorable Outcome in Patients with Oral Squamous Cell Carcinoma.

Kato K, Miyazawa H, Kobayashi H, Noguchi N, Lambert D, Kawashiri S Pathol Oncol Res. 2020; 26(4):2105-2113.

PMID: 31907776 DOI: 10.1007/s12253-019-00791-1.

Possible biomarkers for predicting lymph node metastasis of esophageal squamous cell carcinoma: a review.

Li J, Qi Z, Hu Y, Wang Y J Int Med Res. 2019; 47(2):544-556.

PMID: 30616477 PMC: 6381495. DOI: 10.1177/0300060518819606.

References

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Vega F, Fruhwirth G, Ng T, Ridley A . RhoA and RhoC have distinct roles in migration and invasion by acting through different targets. J Cell Biol. 2011; 193(4):655-65. PMC: 3166870. DOI: 10.1083/jcb.201011038. View

Song Y, Xue L, Du S, Sun M, Hu J, Hao L . Caveolin-1 knockdown is associated with the metastasis and proliferation of human lung cancer cell line NCI-H460. Biomed Pharmacother. 2012; 66(6):439-47. DOI: 10.1016/j.biopha.2012.03.001. View

Isik A, Soyturk M, Suleyman S, Firat D, Peker K, Yilmaz I . Correlation of Bowel Wall Thickening Seen Using Computerized Tomography With Colonoscopies: A Preliminary Study. Surg Laparosc Endosc Percutan Tech. 2017; 27(3):154-157. DOI: 10.1097/SLE.0000000000000389. View

Parton R, Simons K . The multiple faces of caveolae. Nat Rev Mol Cell Biol. 2007; 8(3):185-94. DOI: 10.1038/nrm2122. View

Thomas S, Overdevest J, Nitz M, Williams P, Owens C, Sanchez-Carbayo M . Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer. Cancer Res. 2010; 71(3):832-41. PMC: 4306590. DOI: 10.1158/0008-5472.CAN-10-0730. View

Chen Y, Wang T, Hsu H, Yuan R, Jeng Y . Overexpression of CTHRC1 in hepatocellular carcinoma promotes tumor invasion and predicts poor prognosis. PLoS One. 2013; 8(7):e70324. PMC: 3726622. DOI: 10.1371/journal.pone.0070324. View

Arpaia E, Blaser H, Quintela-Fandino M, Duncan G, Leong H, Ablack A . The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk. Oncogene. 2011; 31(7):884-96. PMC: 3289793. DOI: 10.1038/onc.2011.288. View

Jia Y, Wang N, Wang J, Tian H, Ma W, Wang K . Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis. Ann Surg Oncol. 2013; 21(1):329-36. DOI: 10.1245/s10434-013-3225-x. View

10.

Tse E, Ko F, Tung E, Chan L, Lee T, Ngan E . Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis. J Pathol. 2011; 226(4):645-53. DOI: 10.1002/path.3957. View

11.

Grande-Garcia A, Echarri A, de Rooij J, Alderson N, Waterman-Storer C, Valdivielso J . Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases. J Cell Biol. 2007; 177(4):683-94. PMC: 2064213. DOI: 10.1083/jcb.200701006. View

12.

Kato K, Hida Y, Miyamoto M, Hashida H, Shinohara T, Itoh T . Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer. 2002; 94(4):929-33. View

13.

Shatz M, Liscovitch M . Caveolin-1: a tumor-promoting role in human cancer. Int J Radiat Biol. 2008; 84(3):177-89. DOI: 10.1080/09553000701745293. View

14.

Goetz J, Lajoie P, Wiseman S, Nabi I . Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Rev. 2008; 27(4):715-35. DOI: 10.1007/s10555-008-9160-9. View

15.

Ota T, Maeda M, Suto S, Tatsuka M . LyGDI functions in cancer metastasis by anchoring Rho proteins to the cell membrane. Mol Carcinog. 2004; 39(4):206-20. DOI: 10.1002/mc.20006. View

16.

Bouzahzah B, Albanese C, Ahmed F, Pixley F, Lisanti M, Segall J . Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol Med. 2002; 7(12):816-30. PMC: 1950008. View

17.

Freeman M, Yang W, Di Vizio D . Caveolin-1 and prostate cancer progression. Adv Exp Med Biol. 2012; 729:95-110. DOI: 10.1007/978-1-4614-1222-9_7. View

18.

Isik A, Gursul C, Peker K, Aydin M, Firat D, Yilmaz I . Metalloproteinases and Their Inhibitors in Patients with Inguinal Hernia. World J Surg. 2017; 41(5):1259-1266. DOI: 10.1007/s00268-016-3858-6. View

19.

Liu L, Xu H, Wang W, Wu C, Chen T, Qin Y . Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic cancer. Oncogene. 2013; 33(21):2728-36. DOI: 10.1038/onc.2013.223. View

20.

Enzinger P, Mayer R . Esophageal cancer. N Engl J Med. 2003; 349(23):2241-52. DOI: 10.1056/NEJMra035010. View